OBJECTIVE: To estimate whether progestin-induced endometrial shedding, before ovulation induction with clomiphene citrate, metformin, or a combination of both, affects ovulation, conception, and live birth rates in women with polycystic ovary syndrome (PCOS). METHODS: A secondary analysis of the data from 626 women with PCOS from the Eunice Kennedy Shriver National Institute of Child Health and Human Development Cooperative Reproductive Medicine Network trial was performed. Women had been randomized to up to six cycles of clomiphene citrate alone, metformin alone, or clomiphene citrate plus metformin. Women were assessed for occurrence of ovulation, conception, and live birth in relation to prior bleeding episodes (after either ovulation or exogenous progestin-induced withdrawal bleed). RESULTS: Although ovulation rates were higher in cycles preceded by spontaneous endometrial shedding than after anovulatory cycles (with or without prior progestin withdrawal), both conception and live birth rates were significantly higher after anovulatory cycles without progestin-induced withdrawal bleeding (live births per cycle: spontaneous menses 2.2%; anovulatory with progestin withdrawal 1.6%; anovulatory without progestin withdrawal 5.3%; P<.001). The difference was more marked when rate was calculated per ovulation (live births per ovulation: spontaneous menses 3.0%; anovulatory with progestin withdrawal 5.4%; anovulatory without progestin withdrawal 19.7%; P<.001). CONCLUSION:Conception and live birth rates are lower in women with PCOS after a spontaneous menses or progestin-induced withdrawal bleeding as compared with anovulatory cycles without progestin withdrawal. The common clinical practice of inducing endometrial shedding with progestin before ovarian stimulation may have an adverse effect on rates of conception and live birth in anovulatory women with PCOS. LEVEL OF EVIDENCE: II.
RCT Entities:
OBJECTIVE: To estimate whether progestin-induced endometrial shedding, before ovulation induction with clomiphene citrate, metformin, or a combination of both, affects ovulation, conception, and live birth rates in women with polycystic ovary syndrome (PCOS). METHODS: A secondary analysis of the data from 626 women with PCOS from the Eunice Kennedy Shriver National Institute of Child Health and Human Development Cooperative Reproductive Medicine Network trial was performed. Women had been randomized to up to six cycles of clomiphene citrate alone, metformin alone, or clomiphene citrate plus metformin. Women were assessed for occurrence of ovulation, conception, and live birth in relation to prior bleeding episodes (after either ovulation or exogenous progestin-induced withdrawal bleed). RESULTS: Although ovulation rates were higher in cycles preceded by spontaneous endometrial shedding than after anovulatory cycles (with or without prior progestin withdrawal), both conception and live birth rates were significantly higher after anovulatory cycles without progestin-induced withdrawal bleeding (live births per cycle: spontaneous menses 2.2%; anovulatory with progestin withdrawal 1.6%; anovulatory without progestin withdrawal 5.3%; P<.001). The difference was more marked when rate was calculated per ovulation (live births per ovulation: spontaneous menses 3.0%; anovulatory with progestin withdrawal 5.4%; anovulatory without progestin withdrawal 19.7%; P<.001). CONCLUSION: Conception and live birth rates are lower in women with PCOS after a spontaneous menses or progestin-induced withdrawal bleeding as compared with anovulatory cycles without progestin withdrawal. The common clinical practice of inducing endometrial shedding with progestin before ovarian stimulation may have an adverse effect on rates of conception and live birth in anovulatory women with PCOS. LEVEL OF EVIDENCE: II.
Authors: C A Eagleson; M B Gingrich; C L Pastor; T K Arora; C M Burt; W S Evans; J C Marshall Journal: J Clin Endocrinol Metab Date: 2000-11 Impact factor: 5.958
Authors: Richard E Leach; Philip Jessmon; Christos Coutifaris; Michael Kruger; Evan R Myers; Rouba Ali-Fehmi; Sandra A Carson; Richard S Legro; William D Schlaff; Bruce R Carr; Michael P Steinkampf; Susan Silva; Phyllis C Leppert; Linda Giudice; Michael P Diamond; D Randall Armant Journal: Hum Reprod Date: 2012-01-02 Impact factor: 6.918
Authors: Karla Kohan; Rodrigo Carvajal; Fernando Gabler; David Vantman; Carmen Romero; Margarita Vega Journal: Reproduction Date: 2010-04-20 Impact factor: 3.906
Authors: Heping Zhang; Richard S Legro; Jeffrey Zhang; Leon Zhang; Xiang Chen; Hao Huang; Peter R Casson; William D Schlaff; Michael P Diamond; Stephen A Krawetz; Christos Coutifaris; Robert G Brzyski; Gregory M Christman; Nanette Santoro; Esther Eisenberg Journal: Hum Reprod Date: 2010-08-17 Impact factor: 6.918
Authors: Romina Fornes; Paulina Ormazabal; Carlos Rosas; Fernando Gabler; David Vantman; Carmen Romero; Margarita Vega Journal: Mol Med Date: 2009-12-04 Impact factor: 6.354
Authors: Susan K Blank; Christopher R McCartney; Sandhya Chhabra; Kristin D Helm; Christine A Eagleson; R Jeffrey Chang; John C Marshall Journal: J Clin Endocrinol Metab Date: 2009-04-07 Impact factor: 5.958
Authors: Mary E Rausch; Richard S Legro; Huiman X Barnhart; William D Schlaff; Bruce R Carr; Michael P Diamond; Sandra A Carson; Michael P Steinkampf; Peter G McGovern; Nicholas A Cataldo; Gabriella G Gosman; John E Nestler; Linda C Giudice; Phyllis C Leppert; Evan R Myers; Christos Coutifaris Journal: J Clin Endocrinol Metab Date: 2009-06-09 Impact factor: 5.958
Authors: Bradley S Hurst; Jennifer M Hickman; Michelle L Matthews; Rebecca S Usadi; Paul B Marshburn Journal: Am J Obstet Gynecol Date: 2008-12-27 Impact factor: 8.661
Authors: Richard S Legro; William C Dodson; Allen R Kunselman; Christy M Stetter; Penny M Kris-Etherton; Nancy I Williams; Carol L Gnatuk; Stephanie J Estes; Kelly C Allison; David B Sarwer; Michael P Diamond; William D Schlaff; Peter R Casson; Gregory M Christman; Kurt T Barnhart; G Wright Bates; Rebecca Usadi; Scott Lucidi; Valerie Baker; Heping Zhang; Esther Eisenberg; Christos Coutifaris; Anuja Dokras Journal: J Clin Endocrinol Metab Date: 2016-05-12 Impact factor: 5.958
Authors: Richard S Legro; Robert G Brzyski; Michael P Diamond; Christos Coutifaris; William D Schlaff; Peter Casson; Gregory M Christman; Hao Huang; Qingshang Yan; Ruben Alvero; Daniel J Haisenleder; Kurt T Barnhart; G Wright Bates; Rebecca Usadi; Scott Lucidi; Valerie Baker; J C Trussell; Stephen A Krawetz; Peter Snyder; Dana Ohl; Nanette Santoro; Esther Eisenberg; Heping Zhang Journal: N Engl J Med Date: 2014-07-10 Impact factor: 91.245
Authors: Ilene K Tsui; William C Dodson; Allen R Kunselman; Hongying Kuang; Feng-Juan Han; Richard S Legro; Xiao-Ke Wu Journal: BMJ Open Date: 2016-01-28 Impact factor: 2.692